OVERVIEW

Pharmacovigilance World 2027 Conference is organized by Corvus Global Events (CGE) and will be held from Jun 16 - 17, 2027 in London, England, United Kingdom.

Description:
Pharmacovigilance World 2027 is the definitive platform for global drug safety professionals, regulators, and industry innovators to connect, learn, and shape the future of pharmacovigilance. This event offers unparalleled insights into the tools, strategies, and technologies enhancing drug safety monitoring and regulatory compliance across the pharmaceutical ecosystem.

The conference brings together experts across the PV spectrum to address critical challenges in signal detection, safety systems, automation, and real-world data integration, enabling a more proactive and patient-centric pharmacovigilance system.

The need for effective pharmacovigilance systems becomes even more crucial as the global population continues to expand, resulting in an increased consumption of medications. Adverse drug reactions (ADRs) can have severe consequences, leading to hospitalizations, prolonged treatments, and in some cases, even fatalities. Therefore, it is imperative to enhance our understanding of ADRs, identify potential risks, and implement appropriate risk mitigation strategies. To efficiently address these challenges, collaboration between international regulatory bodies, healthcare providers, and patients is essential. With a strong focus on patient safety as well as public health and by creating an interconnected network of experts from around the world who are dedicated to advancing our understanding of drug safety and pharmacovigilance, we can create a robust system.

This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance.

Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas.

Key Highlights: